Author pages are created from data sourced from our academic publisher partnerships and public sources.
- Publications
- Influence
Canadian implantable defibrillator study (CIDS) : a randomized trial of the implantable cardioverter defibrillator against amiodarone.
- S. Connolly, M. Gent, +7 authors B. O'Brien
- Medicine
- Circulation
- 21 March 2000
BACKGROUND
Patients surviving ventricular fibrillation (VF) or sustained ventricular tachycardia (VT) are at a high risk of death due to a recurrence of arrhythmia. The implantable cardioverter… Expand
Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.
- D. Echt, P. Liebson, +7 authors H. Greene
- Medicine
- The New England journal of medicine
- 21 March 1991
BACKGROUND AND METHODS
In the Cardiac Arrhythmia Suppression Trial, designed to test the hypothesis that suppression of ventricular ectopy after a myocardial infarction reduces the incidence of… Expand
Relationships Between Sinus Rhythm, Treatment, and Survival in the Atrial Fibrillation Follow-Up Investigation of Rhythm Management (AFFIRM) Study
- S. Corley, A. Epstein, +15 authors D. Wyse
- Medicine
- Circulation
- 30 March 2004
Background—The AFFIRM Study showed that treatment of patients with atrial fibrillation and a high risk for stroke or death with a rhythm-control strategy offered no survival advantage over a… Expand
Focused 2012 update of the Canadian Cardiovascular Society atrial fibrillation guidelines: recommendations for stroke prevention and rate/rhythm control.
The Canadian Cardiovascular Society (CCS) published the complete set of 2010 Atrial Fibrillation (AF) Guidelines in the January, 2011 issue of the Canadian Journal of Cardiology. During its… Expand
Noninvasive risk assessment early after a myocardial infarction the REFINE study.
- D. Exner, K. Kavanagh, +15 authors H. Duff
- Medicine
- Journal of the American College of Cardiology
- 11 December 2007
OBJECTIVES
This study sought to determine whether combined assessment of autonomic tone plus cardiac electrical substrate identifies most patients at risk of serious events after myocardial… Expand
Prophylactic Oral Amiodarone for the Prevention of Arrhythmias that Begin Early After Revascularization, Valve Replacement, or Repair: PAPABEAR: a randomized controlled trial.
- L. Mitchell, D. Exner, +9 authors Andrew Maitland
- Medicine
- JAMA
- 28 December 2005
CONTEXT
Atrial tachyarrhythmias after cardiac surgery are associated with adverse outcomes and increased costs. Previous trials of amiodarone prophylaxis, while promising, were relatively small and… Expand
2014 focused update of the Canadian Cardiovascular Society Guidelines for the management of atrial fibrillation.
Atrial fibrillation (AF) is an extremely common clinical problem with an important population morbidity and mortality burden. The management of AF is complex and fraught with many uncertain and… Expand
Assessment of the cardiac patient for fitness to drive: drive subgroup executive summary.
- C. Simpson, P. Dorian, +14 authors F. Brennan
- Medicine
- The Canadian journal of cardiology
- 1 November 2004
Survival After Coronary Revascularization Among Patients With Kidney Disease
- B. Hemmelgarn, D. Southern, B. Culleton, L. Mitchell, M. Knudtson, W. Ghali
- Medicine
- Circulation
- 5 October 2004
Background—The optimal approach to revascularization in patients with kidney disease has not been determined. We studied survival by treatment group (CABG, percutaneous coronary intervention [PCI],… Expand
Sudden death in patients with implantable cardioverter defibrillators: the importance of post-shock electromechanical dissociation.
- L. Mitchell, E. Pineda, J. Titus, Paulette M Bartosch, D. Benditt
- Medicine
- Journal of the American College of Cardiology
- 1 April 2002
OBJECTIVES
The purpose of this study was to determine the mechanisms of sudden death (SD) in patients with ventricular tachyarrhythmias (ventricular tachycardia/ventricular fibrillation [VT/VF])… Expand